Yuki Hasegawa | Bioelectronics and Biomaterials | Research Excellence Award

Published on by TOT Awards

Assoc. Prof. Dr. Yuki Hasegawa | Bioelectronics and Biomaterials | Research Excellence Award

Saitama University | Japan

Assoc. Prof. Dr. Yuki Hasegawa research focuses on advancing sensor technology and measurement systems with strong emphasis on gas sensors, taste sensors, electrochemical sensing, and plant bioelectrical potential measurement for environmental and agricultural applications. Core contributions include the design, fabrication, and evaluation of functional material–based sensors and miniaturized sensing platforms capable of stable, sensitive, and reproducible measurements under real-world conditions. Innovative experimental methodologies and signal analysis techniques have been developed to improve sensor selectivity, long-term stability, and response reliability. Research outcomes support interdisciplinary applications spanning environmental monitoring, smart agriculture, and bio-sensing systems, enabling more accurate detection of chemical and biological signals. The work integrates electrical engineering principles with materials science and measurement engineering, contributing to scalable and practical sensing solutions. Findings have been disseminated through high-impact peer-reviewed international journals and conferences indexed in SCI/SCIE and Scopus, strengthening global knowledge exchange in sensing technologies. Scholarly impact is reflected through citation metrics, with 306 total citations (124 since 2020), an h-index of 9 (6 since 2020), and an i10-index of 9 (2 since 2020), demonstrating consistent research influence and relevance. Overall, the research advances next-generation sensing systems and supports sustainable technological development in environmental and agricultural engineering.

Citation Metrics (Google Scholar)

Total Citations
306

Citations: 306 |
h-index: 9 |
i10-index: 9

🟦 Citations    🟩 h-index    🟥 i10-index


View Google Scholar Profile

Featured Publications

Stylianos Bourmpoutelis | Health Sciences | Young Scientist Award

Published on by TOT Awards

Dr. Stylianos Bourmpoutelis | Health Sciences | Young Scientist Award

Aristotle University of Thessaloniki | Greece

Dr. Stylianos Bourmpoutelis is an emerging researcher in Internal Medicine whose work is strongly centered on HIV medicine, antimicrobial resistance, and the clinical–microbiological interfaces shaping modern infectious disease care. His research activity reflects a sustained commitment to improving patient outcomes through evidence-based clinical strategies, with particular emphasis on vulnerable populations such as people who inject drugs. His contributions include data collection, clinical evaluation, and outcome-driven analysis that support impactful publications in peer-reviewed journals. Bourmpoutelis has participated in multidisciplinary research networks, contributing to studies that integrate public health, infectious diseases, and microbiology in order to optimize care pathways and improve treatment adherence. His scholarly visibility continues to grow through citations in reputable databases and the ongoing expansion of his indexed publications. He maintains active research profiles and consistently updates citation-related documents to ensure transparency and accessibility for the scientific community. Current citation metrics include an estimated Scopus h-index of 2 and a Google Scholar h-index of 3, reflecting the early yet steadily increasing influence of his work. His documented contributions demonstrate strong methodological engagement, rigorous data interpretation, and a readiness to collaborate across clinical and scientific teams. Bourmpoutelis’s research record aligns with the ideals of the Young Scientist Award, showcasing innovation, academic promise, and meaningful contributions to public health research. His scientific outputs emphasize integrated care models, real-world clinical outcomes, and microbiological investigations that collectively advance understanding within internal medicine and infectious disease research. With a growing portfolio of indexed publications and documented research contributions, he continues to establish himself as a dedicated early-career scientist advancing impactful, ethically grounded, and methodologically robust medical research.

Publication Profile

Google Scholar

Featured Publications

Roussos, S., Protopapapas, K., Mastrogianni, E., Totsikas, C., Moschopoulos, C. D., Bourmpoutelis, S., Resta, P., Procter, K., Kokolesis, E., Antoniadou, A., et al. (2025). Rapid ART initiation with BIC/FTC/TAF in people who inject drugs in Greece: Results from a pilot single-arm study of an integrated care model. Microorganisms, 13(12), 2697.

Abduljabbar S. Ba Mahel | Biomedical | Best Researcher Award

Published on by TOT Awards

EMMANUEL SCALAIS | Medicine and Health Sciences | Outstanding Scientist Award

Published on by TOT Awards

Dr.EMMANUELSCALAIS|MedicineandHealth Sciences| Outstanding Scientist Award

MD at NEPE, Luxembourg.

Dr. Emmanuel Scalais is the Chief Physician of the Pediatric Neurology Department at Centre Hospitalier de Luxembourg (CHL)He has authored 82 publications and has been cited 2,877 times in the field of pediatric neurology.His clinical expertise includes conditions such as homocystinuria, vitamin B12 deficiency anemia, and exocrine pancreatic insufficiency.

professional profiles📖

Education 🎓

Secondary School: Humanity Greco-Latine (June 1972), Collège du Sacré-Coeur, Charleroi, BelgiumHigh School: Université Catholique de LouvainBaccalauréat en Philosophie: Magna cum Laude (June 1975)Doctor of Medicine: Laude (June 1979)

work Experience💼

1988-2002: Pediatric Neurologist, CHC Espérance & Saint Vincent, Liège, Belgium (Full-time)Lecturer: Pediatric Neurology Course for nurses at “School of Sainte-Julienne,” LiègeLecturer: “Medical Approach of Handicap” in Orthopédagogie2003-2024: Pediatric Neurologist, Centre Hospitalier de Luxembourg, Department of Pediatrics (Full-time)Head of Pediatric Neurology Division (2014-2018, 2018-2024)Lecturer: Pediatric Neurology Course for nurses at “Lycée Technique pour Professions de Santé” (2006-2024)

Research Focus

Dr. Scalais has authored numerous peer-reviewed articles, with a focus on pediatric neurology, metabolic disorders, and neonatal brain function. Notable contributions include:Research on phenobarbital’s effects on cerebral blood flow in newbornsStudies on very long-chain acyl-CoA dehydrogenase deficiency as a cause of neonatal sudden infant deathInvestigations into early myoclonic epilepsy linked to CoQ10 deficiencyDiagnostic and prognostic value of evoked potentials in neonatal hypoxiaCase studies on mitochondrial disorders, such as Leigh’s encephalopathy and POLG mutationsHydroxocobalamin dose intensification in early-onset cobalamin metabolism defects

Conclusion

Dr. Scalais based on his , , and . While increasing could further strengthen his profile, his current body of work already demonstrates and .is highly suitable for this awardsignificant contributions to pediatric neurology researchclinical impactinternational collaborationshigh-impact publications, principal investigator roles, and research fundingoutstanding scientific meritlong-term dedication to pediatric neurology

📚Publications to Noted

  • Scalais E, Beharry K, Papageorgiou A, Bureau M, Aranda JV (1992). Effects of phenobarbital on cerebral blood flow in the newborn piglet. Developmental Pharmacology and Therapeutics, 19(1), 10-18. [doi: 10.1159/000457457]

  • Scalais E, Bottu J, Wanders RJ, Ferdinandusse S, Waterham HR, De Meirleir L (2015). Familial very long chain acyl-CoA dehydrogenase deficiency as a cause of neonatal sudden infant death: improved survival by prompt diagnosis. American Journal of Medical Genetics Part A, 167A(1), 211-214. [doi: 10.1002/ajmg.a.36803]

  • Scalais E, Chafai R, Van Coster R, Bindl L, Nuttin C, Panagiotaraki C, Seneca S, Lissens W, Ribes A, Geers C, Smet J, De Meirleir L (2013). Early myoclonic epilepsy, hypertrophic cardiomyopathy and subsequently a nephrotic syndrome in a patient with CoQ10 deficiency caused by mutations in para-hydroxybenzoate-polyprenyl transferase (COQ2). European Journal of Paediatric Neurology, 17(6), 625-630. [doi: 10.1016/j.ejpn.2013.05.013]

  • Scalais E, Connerotte AC, Despontin K, Biver A, Ceuterick-de Groote C, Alders M, Kolivras A, Hachem JP, De Meirleir L (2016). Shwachman-Diamond syndrome presenting with early ichthyosis, associated dermal and epidermal intracellular lipid droplets, hypoglycemia, and later distinctive clinical SDS phenotype. American Journal of Medical Genetics Part A, 170(7), 1799-1805. [doi: 10.1002/ajmg.a.37673]

  • Scalais E, Francois A, Nuttin C (1996). [Diagnostic and prognostic value of evoked potentials facing cerebral hypoxia in newborn infants]. Archives de Pédiatrie, 3 Suppl 1, 251s-253s. [doi: 10.1016/0929-693x(96)86058-1]

  • Scalais E, Francois B, Schlesser P, Stevens R, Nuttin C, Martin JJ, Van Coster R, Seneca S, Roels F, Van Goethem G, Lofgren A, De Meirleir L (2012). Polymerase gamma deficiency (POLG): clinical course in a child with a two-stage evolution from infantile myocerebrohepatopathy spectrum to an Alpers syndrome and neuropathological findings of Leigh’s encephalopathy. European Journal of Paediatric Neurology, 16(5), 542-548. [doi: 10.1016/j.ejpn.2012.01.013]

  • Scalais E, Francois-Adant A, Nuttin C, Bachy A, Guerit JM (1998). Multimodality evoked potentials as a prognostic tool in term asphyxiated newborns. Electroencephalography and Clinical Neurophysiology, 108(2), 199-207. [doi: 10.1016/s0168-5597(97)00076-2]

  • Scalais E, Geron C, Pierron C, Cardillo S, Schlesser V, Mataigne F, Borde P, Regal L (2023). Would early versus late hydroxocobalamin dose intensification treatment prevent cognitive decline, macular degeneration and ocular disease in 5 patients with early-onset cblC deficiency? Molecular Genetics and Metabolism, 140(3), 107681. [doi: 10.1016/j.ymgme.2023.107681]

  • Scalais E, Nuttin C, Seneca S, Smet J, De Paepe B, Martin JJ, Stevens R, Pierart F, Battisti O, Lissens W, De Meirleir L, Van Coster R (2007). Infantile presentation of the mitochondrial A8344G mutation. European Journal of Neurology, 14(11), e3-5. [doi: 10.1111/j.1468-1331.2007.01926.x]

  • Scalais E, Osterheld E, Geron C, Pierron C, Chafai R, Schlesser V, Borde P, Regal L, Laeremans H, van Gassen KLI, van den Heuvel LPWJ, De Meirleir L (Under revision). Parenteral Hydroxocobalamin Dose Intensification in 5 Patients with Different Types of Early Onset Intracellular Cobalamin Defects: Clinical and Biochemical Responses. Journal of Inherited Metabolic Disease.